journal of men's health RSS feed: Current Issue. Journal of Men's Health is a comprehensive, accessible resource of knowledge directly applicable to the daily care of patients, offering key information and insight about men's health and gender medicine to other healthcare professionals, patient groups and policy makers. Topics covered include the fields of family medicine and primary care, urology and andrology, internal medicine and oncology, pediatric and adolescent health, sexual medicine, aging and geriatric medicine, nutrition and well being, preventive and sports medicine, mental health including psychosomatic and psychosocial medicine, public health, social medicine, gender medicine, and basic science. Peer reviewed research and reviews, best practice guidelines, literature overviews, educational materials including self-test CME, commentaries and debate, industry and product news will be published. Electronic usage: An increasing number of readers access the journal online via ScienceDirect, one of the world's most advanced web delivery systems for scientific, technical and medical information. Average monthly article downloads for this journal: 2,720* * Figure is an average based on full text articles downloaded monthly via ScienceDirect between August 2008 and March 2009 For more information on the journal please contact the Publisher, Chris Hammond or the Editor in Chief, Prof. Meryn . For other journal or Society information please contact the Secretariat, Helga Reiter . For sponsorship and advertising opportunities, please contact Sarah Cahill . For information on publishing supplements to the journal, please contact Magda Scheijgrond . Your comments and feedback are very welcome via jmh http://www.jmhjournal.org/?rss=yesElsevier Inc.en © 2010 Published by Elsevier Inc. All rights reserved. journal of men's health1875-686772June 2010 © 2010 Published by Elsevier Inc. All rights reserved. healthpermissions@elsevier.comhttp://www.jmhjournal.org/article/PIIS1875686710000412/abstract?rss=yesEditorial Board10.1016/S1875-6867(10)00041-2journal of men's health 7, 2 (2010)2010-06-01journal of men's health2010-06-0172S1875-6867(10)X0003-3iiiiiihttp://www.jmhjournal.org/article/PIIS1875686710000382/abstract?rss=yesContents10.1016/S1875-6867(10)00038-2journal of men's health 7, 2 (2010)2010-06-01journal of men's health2010-06-0172S1875-6867(10)X0003-3105105http://www.jmhjournal.org/article/PIIS1875686710000333/abstract?rss=yesEffective prevention, diagnosis and management of prostate problems are often hampered by the perception that they are the inevitable consequences of aging and the misconception that little can be done for the affected men and their respective prostate problems. It is clear that there is a need for far greater education among men and their care-giving physicians to increase their knowledge not only about the prostate but also about prostate health in order to encourage men to consult with their physicians, thus improving screening and disease prevention, facilitating early diagnosis and allowing the appropriate treatment of prostate diseases and improving men's health in general.Prostate health: a new gateway to Men's HealthSiegfried Meryn10.1016/j.jomh.2010.05.001journal of men's health 7, 2 (2010)2010-06-01journal of men's health2010-06-0172S1875-6867(10)X0003-3Editor-in-Chief Editorial106107http://www.jmhjournal.org/article/PIIS187568671000031X/abstract?rss=yesISMH has launched its redesigned homepage10.1016/j.jomh.2010.03.004journal of men's health 7, 2 (2010)2010-06-01journal of men's health2010-06-0172S1875-6867(10)X0003-3ISMH News and Views108110http://www.jmhjournal.org/article/PIIS1875686710000321/abstract?rss=yesWork begins on Europe's first-ever men's health report10.1016/j.jomh.2010.03.005journal of men's health 7, 2 (2010)2010-06-01journal of men's health2010-06-0172S1875-6867(10)X0003-3EMHF News111112http://www.jmhjournal.org/article/PIIS1875686710000266/abstract?rss=yesAbstract: Many men who reach average life expectancy will experience benign prostatic hyperplasia (BPH) or prostate cancer and together these conditions account for a considerable amount of ill-health and distress for men and their partners. Although there is considerable overlap across BPH and prostate cancer in symptom and risk profiles, management approaches are very different for each condition and appropriate diagnostic evaluation is therefore crucial to achieve the best possible outcome. The primary care physician should play a vital role in the diagnosis, management and appropriate referral of men with prostate disease with the ultimate goals being (1) early detection of prostate cancer and (2) effective treatment of benign prostate disease to manage symptoms and reduce the risk of progression.In prostate cancer, although there is debate over the implementation of systematic prostate-specific antigen (PSA) screening and appropriate thresholds, the use of PSA screening in conjunction with digital rectal examination (DRE) may aid earlier detection. The challenge is now to better determine which men are likely to develop aggressive disease so that overtreatment can be avoided. Results of large trials of systematic PSA screening are eagerly anticipated.In BPH, a major challenge is to identify men with bothersome lower urinary tract symptoms. Improved communication, education of patients, and the use of tools such as the International Prostate Symptom Score (IPSS) may help detect men who need treatment. Treatment selection should be driven by an understanding of the risks of disease progression, the impact of the disease on the patient's quality of life, and by the patient's own treatment preferences.Ultimately, we must empower our patients to make informed decisions about their diagnostic and treatment options through open dialogue and provision of appropriate information and education.Managing benign prostatic hyperplasia and prostate cancer – the challenges todayMichael Marberger10.1016/j.jomh.2009.12.007journal of men's health 7, 2 (2010)2010-06-01journal of men's health2010-06-0172S1875-6867(10)X0003-3Review113124http://www.jmhjournal.org/article/PIIS1875686710000291/abstract?rss=yesAbstract: Background: The aim of this study was to measure the incidence of anxiety–depression comorbidity among a sample of prostate cancer (PCa) patients and to investigate the total score, factor score and scale item differences across subgroups defined according to the presence of anxiety and/or depression.Methods: 491 PCa patients who had received their initial diagnosis between 1 and 113 months previously completed a survey of background variables, as well as the Zung Self-Rating Anxiety and Depression Scales (SAS, SDS).Results: Incidence of anxiety–depression comorbidity was nearly 16%, and higher than that previously reported in other samples. Although the directional differences of total anxiety and depression scores were as expected, analysis of underlying factor structures suggested significant overlap between anxiety and depression symptomatologies, and this was supported by analysis of scale item differences across disorder subgroups.Conclusions: Comorbidity of anxiety and depression may be higher during treatment procedures and following treatment than has been previously suggested from data collected at the commencement of treatment for PCa. Diagnosis of anxiety or depression may benefit from consideration of symptoms that are more traditionally associated with the alternative disorder, thus potentially modifying treatment and support plans for PCa patients with these psychosocial disorders.Incidence and nature of anxiety–depression comorbidity in prostate cancer patientsChristopher F. Sharpley, Vicki Bitsika, David R.H. Christie10.1016/j.jomh.2010.03.003journal of men's health 7, 2 (2010)2010-06-01journal of men's health2010-06-0172S1875-6867(10)X0003-3Original articles125134http://www.jmhjournal.org/article/PIIS1875686710000278/abstract?rss=yesAbstract: Background: This study examines differences in medical self advocacy in men by racial/ethnic group.Methods: This study used data from the 2000–2001 Household Component of the Community Tracking Survey. The study sample included 14,527 men aged 18–65 with at least 1 physician visit in the previous year. Binomial logit models were used to examine the predictors of self advocacy.Results: Compared to White men, Hispanic and African American men were slightly more likely to seek health information (odds ratio (OR) = 1.05) and (OR = 1.13), however the finding was not significant. African American (0R = 0.59) men were less likely to mention health information they sought to a physician during the medical encounter than White men. Among those men who sought health information and mentioned that information to a physician, Hispanic men (OR = 3.57) were more likely to perceive that tests were ordered based upon health information mentioned to the physician than White men.Conclusions: It is important for future studies to explore interventions to improve how African American men interface with the healthcare system.Men and differences by racial/ethnic group in self advocacy during the medical encounterKeith T. Elder, Jacqueline C. Wiltshire, Luceta McRoy, Dayna Campbell, Lisa C. Gary, Monika Safford10.1016/j.jomh.2010.03.001journal of men's health 7, 2 (2010)2010-06-01journal of men's health2010-06-0172S1875-6867(10)X0003-3Original articles135144http://www.jmhjournal.org/article/PIIS1875686710000308/abstract?rss=yesAbstract: This article presents a further exploration of the risk factors underlying cardiometabolic (CM) disease and their identification and management within an integrative medicine framework as illustrated by the case of a 30-year-old obese African American male who presented for a follow-up visit with regard to his metabolic syndrome (MeS).This article reviews in detail the pathophysiology of common nutrient depletions and their contribution to CM disease risk, as well as drug-induced nutrient depletions incurred during treatment for CM disease and the MeS. The review also includes a detailed discussion on the evaluation and treatment of nutrient deficiencies.The article concludes with a detailed discussion of the case resolution. Following an extensive metabolic evaluation, a program of specific nutrient repletion was instituted alongside testosterone replacement therapy in addition to instituting stress reduction techniques and herbal supplements to improve his physiologic stress response. The patient returned to clinic after 3 months to review progress and laboratory results. He had lost 15 pounds, reported increased energy levels, and complete elimination of joint aches. He was scheduled to return to the clinic after a further 3 months for re-evaluation.An integrative medicine approach to managing nutrient depletions in the cardiometabolic patientAndrew Heyman, James B. Lavalle, Ernest B. Hawkins, Lena Edwards10.1016/j.jomh.2010.01.002journal of men's health 7, 2 (2010)2010-06-01journal of men's health2010-06-0172S1875-6867(10)X0003-3Academic Men's Health - Case Studies145158http://www.jmhjournal.org/article/PIIS187568671000028X/abstract?rss=yesEvents 201010.1016/j.jomh.2010.03.002journal of men's health 7, 2 (2010)2010-06-01journal of men's health2010-06-0172S1875-6867(10)X0003-3Updates159160